ArticleClinical and translational science2025

Characterization of Drug-Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS-CoV-2, in Healthy Participants.

Jack Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.